(BMRN) Biomarin Pharmaceutical complete technical analysis [charts+indicators] | Buy/Sell Biomarin Pharmaceutical | (BMRN) share price targets
Complete technical analysis of Biomarin Pharmaceutical (BMRN) by charts plus indicators, forecast predictions and share price targets for Biomarin Pharmaceutical (BMRN)
Biomarin Pharmaceutical trades in USA in Health Care sector.
Showing technical analysis as on 2025-09-05 View latest technical analysis
10 day averaged volume of Biomarin Pharmaceutical is 1661380
| Date | Daily Closing Price | Open | High | Low | Volume |
| 05 Fri Sep 2025 | 57.77 | 56.64 | 58.03 | 56.58 | 0.882 times |
| 04 Thu Sep 2025 | 56.75 | 58.91 | 58.91 | 55.99 | 1.445 times |
| 03 Wed Sep 2025 | 58.98 | 59.23 | 59.79 | 58.53 | 0.855 times |
| 02 Tue Sep 2025 | 59.09 | 58.40 | 59.24 | 58.25 | 1.033 times |
| 29 Fri Aug 2025 | 58.27 | 57.54 | 58.35 | 57.30 | 0.764 times |
| 29 Fri Aug 2025 | 58.27 | 57.54 | 58.35 | 57.30 | 0.764 times |
| 28 Thu Aug 2025 | 57.68 | 58.47 | 58.64 | 57.32 | 0.749 times |
| 27 Wed Aug 2025 | 58.66 | 57.50 | 58.80 | 57.42 | 1.024 times |
| 26 Tue Aug 2025 | 57.45 | 58.65 | 58.72 | 57.15 | 1.334 times |
| 25 Mon Aug 2025 | 58.50 | 58.88 | 58.94 | 57.55 | 1.036 times |
My analysis of stock is bearish for shortterm, and stock might move down till 57.2 or till 56.4. Use a stoploss of 57.91 and if the stock hits stoploss, then it can shoot up till 58.58
Share price targets for Biomarin Pharmaceutical (BMRN)
| Target Type | Value |
| Downside Target | 53.72 |
| Downside Target | 55.99 |
| Upside Target | 58.59 |
| Upside Target | 58.85 |
| Upside Target | 58.94 |
| Upside Target | 59.09 |
| Upside Target | 59.79 |
| Upside Target | 60.43 |
| Upside Target | 63.97 |
| Upside Target | 65.40 |
Intraday share price targets for Biomarin Pharmaceutical (BMRN)
| Target Type | Value |
| Downside Intraday Target | 55.91 |
| Downside Intraday Target | 54.05 |
| Upside Intraday Target | 59.71 |
| Upside Intraday Target | 61.65 |
| Upside Intraday Target | 57.85 |
Weekly technical analysis of Biomarin Pharmaceutical (BMRN)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 05 Fri Sep 2025 | 57.77 | 58.40 | 59.79 | 55.99 | 5.515 times |
| 29 Fri Aug 2025 | 58.27 | 57.54 | 58.35 | 57.30 | 0.156 times |
| 29 Fri Aug 2025 | 58.27 | 58.88 | 58.94 | 57.15 | 1.025 times |
| 22 Fri Aug 2025 | 58.58 | 57.68 | 58.85 | 57.16 | 0.765 times |
| 15 Fri Aug 2025 | 57.54 | 56.92 | 59.09 | 56.45 | 0.702 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Biomarin Pharmaceutical (BMRN)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 05 Fri Sep 2025 | 57.77 | 58.40 | 59.79 | 55.99 | 0.151 times |
| 29 Fri Aug 2025 | 58.27 | 57.50 | 63.97 | 56.36 | 1.168 times |
| 31 Thu Jul 2025 | 57.85 | 54.64 | 60.43 | 54.63 | 0.938 times |
| 30 Mon Jun 2025 | 54.97 | 57.99 | 58.59 | 53.72 | 0.925 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Biomarin Pharmaceutical (BMRN)
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Biomarin Pharmaceutical in short term and the sell signal is strong.
Biomarin Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Biomarin Pharmaceutical in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biomarin Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 58.06 and Biomarin Pharmaceutical (BMRN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Biomarin Pharmaceutical in short term and the sell signal is strong.
Biomarin Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Biomarin Pharmaceutical in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biomarin Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 58.06 and Biomarin Pharmaceutical (BMRN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.